GGrantIndex
← Search

AN IMPLANTABLE MICRODEVICE FOR EFFICIENT IN VIVO TESTING OF TARGETED THERAPIES IN OVARIAN CLEAR CELL CANCER

$358,272FY2022Defense Health AgencyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →
AN IMPLANTABLE MICRODEVICE FOR EFFICIENT IN VIVO TESTING OF TARGETED THERAPIES IN OVARIAN CLEAR CELL CANCER · GrantIndex